✦ LIBER ✦

Cost effectiveness analysis of disease modifying antirheumatic drugs in rheumatoid arthritis

✍ Scribed by Manathip Osiri; Pirom Kamolratanakul; Andreas Maetzel; Peter Tugwell

Publisher: Springer
Year: 2007
Tongue: English
Weight: 242 KB
Volume: 27
Category: Article
ISSN: 0172-8172
DOI: 10.1007/s00296-007-0342-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Conventional disease-modifying antirheum

Conventional disease-modifying antirheumatic drugs to treat rheumatoid arthritis

✍ T. Rath; O. Sander; A. Rubbert 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Laboratory testing in rheumatoid arthrit

Laboratory testing in rheumatoid arthritis patients taking disease-modifying antirheumatic drugs: Clinical evaluation and cost analysis

✍ Aletaha, Daniel ;Smolen, Josef S. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

The early use of disease-modifying antir

The early use of disease-modifying antirheumatic drugs in rheumatoid arthritis

✍ Edward S. Mongan 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

Cost-effectiveness of biologic response

Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: A systematic review

✍ Gabrielle van der Velde; Ba' Pham; Márcio Machado; Luciano Ieraci; William Witte 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 172 KB 👁 2 views

Cost effectiveness of adding leflunomide

Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

✍ Maetzel, Andreas ;Strand, Vibeke ;Tugwell, Peter ;Wells, George ;Bombardier, Cla 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

Cost-effectiveness of biologics in polya

Cost-effectiveness of biologics in polyarticular-course juvenile idiopathic arthritis patients unresponsive to disease-modifying antirheumatic drugs

✍ Wendy J. Ungar; Vania Costa; Rebecca Hancock-Howard; Brian M. Feldman; Ronald M. 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 150 KB 👁 2 views

## Abstract ## Objective Juvenile idiopathic arthritis (JIA) is the most common chronic pediatric rheumatic disease and can have long‐term effects leading to disability in adulthood. Biologics are a new class of drugs increasingly used to treat JIA. The primary study objective was to determine the